Portfolio of Renaissance Technologies
Renaissance Technologies was founded by Jim Simons († 2024) and makes investment decisions with mathematical models; the portfolio holds a very large number of stocks.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 13, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2019. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 130.1B USD
- Positions
- 3,469
- Share of the ten largest
- 12.7%
The ten largest positions Q4 2019
- Bristol Myers Squibb 3.0%▲ +83.8%
- Tesla, Inc. 1.3%▲ +486.9%
- Verisign 1.2%▼ −0.1%
- Vertex Pharmaceuticals 1.2%▲ +22.0%
- Novo Nordisk (ADR) 1.2%▲ +5.8%
- Chipotle Mexican Grill 1.1%▼ −7.9%
- Biogen 1.0%▲ +8.3%
- Palo Alto Networks 1.0%▼ −3.2%
- Gilead Sciences 0.8%▲ +15.1%
- Humana 0.8%▼ −0.2%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2019
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| BMY Bristol Myers Squibb | 3.0% | 60,210,661 | 3.9B USD | +83.8% increased | Q2 2016 15 quarters |
| TSLA Tesla, Inc. | 1.3% | 3,938,142 | 1.6B USD | +486.9% increased | Q4 2018 5 quarters |
| VRTX Vertex Pharmaceuticals | 1.2% | 7,076,582 | 1.5B USD | +22.0% increased | Q1 2017 12 quarters |
| NVO Novo Nordisk (ADR) | 1.2% | 26,217,026 | 1.5B USD | +5.8% increased | Q2 2013 or earlier 27 quarters |
| BIIB Biogen | 1.0% | 4,569,906 | 1.4B USD | +8.3% increased | Q1 2018 8 quarters |
| GILD Gilead Sciences | 0.8% | 16,962,944 | 1.1B USD | +15.1% increased | Q4 2014 21 quarters |
| WMT Walmart | 0.8% | 8,926,837 | 1.1B USD | +22.1% increased | Q4 2018 5 quarters |
| ABBV AbbVie | 0.8% | 11,796,744 | 1.0B USD | +61.5% increased | Q1 2018 8 quarters |
| Allergan PLC | 0.7% | 5,019,812 | 959.6M USD | +36.6% increased | Q1 2017 12 quarters |
| Petroleo Brasileiro SA Petro | 0.7% | 56,695,930 | 903.7M USD | +30.6% increased | Q2 2016 15 quarters |
| Glaxosmithkline PLC | 0.7% | 19,027,599 | 894.1M USD | +8.4% increased | Q2 2013 or earlier 27 quarters |
| GE GE Aerospace | 0.6% | 75,624,926 | 844.0M USD | +25.6% increased | Q1 2019 4 quarters |
| TEAM Atlassian | 0.6% | 6,081,924 | 731.9M USD | +11.6% increased | Q2 2016 15 quarters |
| ALGN Align Technology | 0.6% | 2,610,848 | 728.5M USD | +17.8% increased | Q2 2013 or earlier 27 quarters |
| MNST Monster Beverage | 0.6% | 11,452,315 | 727.8M USD | +20.3% increased | Q1 2014 24 quarters |
| TGT Target Corporation | 0.6% | 5,671,968 | 727.2M USD | +36.5% increased | Q1 2019 4 quarters |
| Vodafone Group PLC New | 0.5% | 33,972,220 | 656.7M USD | +15.9% increased | Q3 2015 18 quarters |
| Novartis A G | 0.5% | 6,601,182 | 625.1M USD | +26.8% increased | Q3 2013 26 quarters |
| FTNT Fortinet | 0.5% | 5,750,888 | 614.0M USD | +35.5% increased | Q3 2015 18 quarters |
| ETR Entergy | 0.5% | 4,898,624 | 586.9M USD | +2.0% increased | Q3 2014 22 quarters |
| EBAY eBay Inc. | 0.4% | 15,120,028 | 546.0M USD | +32.5% increased | Q1 2019 4 quarters |
| Jazz Pharmaceuticals PLC | 0.4% | 3,549,371 | 529.9M USD | +13.8% increased | Q2 2015 19 quarters |
| MRK Merck & Co. | 0.4% | 5,673,243 | 516.0M USD | +40.2% increased | Q2 2019 3 quarters |
| PFE Pfizer | 0.4% | 13,102,541 | 513.4M USD | +205.9% increased | Q1 2019 4 quarters |
| QCOM Qualcomm | 0.4% | 5,756,507 | 507.9M USD | +346.1% increased | Q3 2019 2 quarters |
| FE FirstEnergy | 0.4% | 10,268,300 | 499.0M USD | +6.9% increased | Q1 2014 24 quarters |
| Franco Nevada Corp | 0.4% | 4,639,636 | 479.3M USD | +5.3% increased | Q1 2014 24 quarters |
| Sprint Corporation | 0.4% | 90,053,960 | 469.2M USD | +6.7% increased | Q4 2017 9 quarters |
| Cable One Inc | 0.3% | 292,900 | 436.0M USD | +1.2% increased | Q4 2015 17 quarters |
| CME CME Group | 0.3% | 2,134,418 | 428.4M USD | +31.6% increased | Q2 2018 7 quarters |
| National Grid PLC | 0.3% | 6,832,767 | 428.2M USD | +0.9% increased | Q2 2017 11 quarters |
| Herbalife Nutrition Ltd | 0.3% | 8,561,703 | 408.1M USD | +5.4% increased | Q3 2015 18 quarters |
| Icon PLC | 0.3% | 2,347,059 | 404.2M USD | +1.6% increased | Q2 2013 or earlier 27 quarters |
| Alexion Pharmaceuticals Inc | 0.3% | 3,731,144 | 403.5M USD | +30.9% increased | Q3 2018 6 quarters |
| Mobile Telesystems Pjsc | 0.3% | 39,612,969 | 402.1M USD | +21.5% increased | Q3 2014 22 quarters |
| NEM Newmont | 0.3% | 9,234,499 | 401.2M USD | +27.1% increased | Q3 2017 10 quarters |
| STX Seagate Technology | 0.3% | 6,731,871 | 400.5M USD | +58.9% increased | Q2 2018 7 quarters |
| FFIV F5, Inc. | 0.3% | 2,865,374 | 400.1M USD | +24.8% increased | Q3 2014 22 quarters |
| Abiomed Inc | 0.3% | 2,323,023 | 396.3M USD | +8.8% increased | Q1 2015 20 quarters |
| Bausch Health Cos Inc | 0.3% | 12,491,799 | 373.8M USD | +146.8% increased | Q3 2018 6 quarters |
| Horizon Therapeutics Pub Ltd | 0.3% | 10,100,675 | 365.6M USD | +8.0% increased | Q2 2019 3 quarters |
| Marketaxess HLDGS Inc | 0.3% | 955,954 | 362.4M USD | +33.1% increased | Q4 2016 13 quarters |
| FOXA Fox Corporation (Class A) | 0.3% | 9,349,489 | 346.6M USD | +8.1% increased | Q1 2019 4 quarters |
| NTES NetEase | 0.3% | 1,124,717 | 344.9M USD | +163.8% increased | Q2 2019 3 quarters |
| CSX CSX Corporation | 0.3% | 4,714,225 | 341.1M USD | +80.5% increased | Q2 2018 7 quarters |
| PSA Public Storage | 0.3% | 1,531,872 | 326.2M USD | +0.8% increased | Q2 2016 15 quarters |
| CL Colgate-Palmolive | 0.2% | 4,672,627 | 321.7M USD | +2.4% increased | Q2 2013 or earlier 27 quarters |
| Exelixis Inc | 0.2% | 17,953,926 | 316.3M USD | +20.9% increased | Q3 2016 14 quarters |
| Dropbox Inc | 0.2% | 17,599,516 | 315.2M USD | +54.1% increased | Q1 2019 4 quarters |
| INCY Incyte | 0.2% | 3,601,003 | 314.4M USD | +31.3% increased | Q4 2017 9 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 1,815 positions.
Breakdown by sector
- Health Care 11.6%
- Technology 7.0%
- Consumer Discretionary 6.1%
- Utilities 4.3%
- Consumer Staples 4.1%
- Industrials 2.4%
- Real Estate 2.0%
- Communication Services 1.9%
- Financials 1.5%
- Energy 1.5%
- Materials 0.7%
- not in our coverage 56.9%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors